Falko G. Falkner

3.4k total citations · 1 hit paper
56 papers, 2.9k citations indexed

About

Falko G. Falkner is a scholar working on Genetics, Epidemiology and Virology. According to data from OpenAlex, Falko G. Falkner has authored 56 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 25 papers in Epidemiology and 24 papers in Virology. Recurrent topics in Falko G. Falkner's work include Virus-based gene therapy research (26 papers), Poxvirus research and outbreaks (23 papers) and Herpesvirus Infections and Treatments (11 papers). Falko G. Falkner is often cited by papers focused on Virus-based gene therapy research (26 papers), Poxvirus research and outbreaks (23 papers) and Herpesvirus Infections and Treatments (11 papers). Falko G. Falkner collaborates with scholars based in Austria, United States and Germany. Falko G. Falkner's co-authors include Hans G. Zachau, Bernard Moss, Friedrich Dorner, Friedrich Scheiflinger, G. Antoine, Georg W. Holzer, Perry Barrett, Ralph Mocikat, Helga Savidis-Dacho and Thomas R. Kreil and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Falko G. Falkner

56 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correct transcription of an immunoglobulin κ gene requires an upstream fragment containing conserved sequence elements

1984 583 citations Falko G. Falkner, Hans G. Zachau profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Falko G. Falkner Austria	25	1.1k	1.1k	1.1k	874	789	56	2.9k
Klaus Cichutek Germany	32	1.1k 1.0×	1.3k 1.2×	1.5k 1.4×	1.5k 1.7×	618 0.8×	114	3.5k
John W. Wills United States	38	1.5k 1.3×	1.9k 1.7×	1.2k 1.1×	1.1k 1.2×	870 1.1×	62	3.8k
M. Mackett United Kingdom	28	1.4k 1.3×	1.7k 1.6×	733 0.7×	1.2k 1.4×	783 1.0×	51	3.5k
Hisatoshi Shida Japan	33	1.4k 1.2×	1.0k 1.0×	1.1k 1.0×	751 0.9×	2.3k 3.0×	99	4.5k
David Derse United States	44	1.3k 1.2×	948 0.9×	1.6k 1.4×	868 1.0×	2.4k 3.0×	90	4.9k
Paula M. Cannon United States	37	1.6k 1.4×	864 0.8×	2.3k 2.1×	1.6k 1.8×	709 0.9×	79	4.4k
Robert Drillien France	28	1.3k 1.2×	1.5k 1.4×	954 0.9×	1.0k 1.2×	480 0.6×	74	2.9k
Welkin E. Johnson United States	31	2.0k 1.8×	1.1k 1.0×	1.1k 1.0×	507 0.6×	1.2k 1.6×	75	3.5k
Arifa S. Khan United States	27	636 0.6×	577 0.5×	936 0.9×	892 1.0×	532 0.7×	97	2.3k
Maxine L. Linial United States	34	1.2k 1.1×	1.1k 1.0×	1.5k 1.4×	1.2k 1.4×	424 0.5×	79	3.5k

Countries citing papers authored by Falko G. Falkner

Since Specialization

Citations

This map shows the geographic impact of Falko G. Falkner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Falko G. Falkner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Falko G. Falkner more than expected).

Fields of papers citing papers by Falko G. Falkner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Falko G. Falkner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Falko G. Falkner. The network helps show where Falko G. Falkner may publish in the future.

Co-authorship network of co-authors of Falko G. Falkner

This figure shows the co-authorship network connecting the top 25 collaborators of Falko G. Falkner. A scholar is included among the top collaborators of Falko G. Falkner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Falko G. Falkner. Falko G. Falkner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lengler, Johannes, Markus Weiller, Maria Schuster, et al.. (2025). Preclinical development of TAK-754, a high-performance AAV8-based vector expressing coagulation factor VIII. Molecular Therapy — Methods & Clinical Development. 33(1). 101424–101424. 1 indexed citations

Lengler, Johannes, et al.. (2020). Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release. Molecular Therapy — Methods & Clinical Development. 17. 581–588. 14 indexed citations

Schäfer, Birgit, Georg W. Holzer, Michael G. Schwendinger, et al.. (2011). Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever. PLoS ONE. 6(9). e24505–e24505. 25 indexed citations

Holzer, Georg W., Gerald Aichinger, Helga Savidis-Dacho, et al.. (2011). Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection. Vaccine. 29(24). 4132–4141. 30 indexed citations

Orlinger, Klaus K., Georg W. Holzer, Julia Schwaiger, et al.. (2010). An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system. Vaccine. 28(19). 3318–3324. 21 indexed citations

Schwendinger, Michael G., Georg W. Holzer, Nicolas Sabarth, et al.. (2010). A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations. PLoS ONE. 5(8). e12217–e12217. 30 indexed citations

Holzer, Georg W. & Falko G. Falkner. (2003). Poxviral/Retroviral Chimeric Vectors Allow Cytoplasmic Production of Transducing Defective Retroviral Particles. Humana Press eBooks. 76. 565–578. 1 indexed citations

Himmelspach, Michèle, Michael Pfleiderer, Bernhard Fischer, et al.. (2000). Recombinant Human Factor X. Thrombosis Research. 97(2). 51–67. 17 indexed citations

Antoine, G., Friedrich Scheiflinger, Friedrich Dorner, & Falko G. Falkner. (1998). The Complete Genomic Sequence of the Modified Vaccinia Ankara Strain: Comparison with Other Orthopoxviruses. Virology. 244(2). 365–396. 421 indexed citations

10.

Scheiflinger, Friedrich, Friedrich Dorner, & Falko G. Falkner. (1998). Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus. Archives of Virology. 143(3). 467–474. 18 indexed citations

11.

Gruber, Franz, et al.. (1998). Precise Quantitation of Human Parvovirus B19 DNA in Biological Samples by PCR. Biologicals. 26(3). 213–216. 7 indexed citations

12.

Hämmerle, Thomas, Michèle Himmelspach, Friedrich Dorner, & Falko G. Falkner. (1997). A sensitive PCR assay system for the quantitation of viral genome equivalents: human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV). Archives of Virology. 142(7). 1297–1306. 10 indexed citations

13.

Himmelspach, Michèle, Franz Gruber, Gerhard Antoine, et al.. (1996). Specific Quantitation of Genomic DNA in the Femtogram Range by Amplification of Repetitive Sequences. Analytical Biochemistry. 242(2). 240–247. 4 indexed citations

14.

Antoine, Gerhard, Friedrich Scheiflinger, Georg W. Holzer, et al.. (1996). Characterization of the vaccinia MVA hemagglutinin gene locus and its evaluation as an insertion site for foreign genes. Gene. 177(1-2). 43–46. 12 indexed citations

15.

Hämmerle, Thomas, Falko G. Falkner, & Friedrich Dorner. (1996). A sensitive PCR assay system for the quantitation of viral genome equivalents: hepatitis C virus (HCV). Archives of Virology. 141(11). 2103–2114. 11 indexed citations

16.

Pfleiderer, Michael, Falko G. Falkner, & Friedrich Dorner. (1996). Deletion of the myristylation signal allows high-level production of the hepatitis B virus large surface glycoprotein preS1 with vaccinia virus recombinants. Gene. 176(1-2). 131–137. 2 indexed citations

17.

Falkner, Falko G., et al.. (1996). Overexpression of Human Prothrombin in Permanent Cell Lines Using a Dominant Selection/Amplification Fusion Marker. Protein Expression and Purification. 8(3). 358–364. 3 indexed citations

18.

Falkner, Falko G., P. L. Turecek, Ross T. A. MacGillivray, et al.. (1992). High Level Expression of Active Human Prothrombin in a Vaccina Virus Expression System. Thrombosis and Haemostasis. 68(2). 119–124. 12 indexed citations

19.

Scheiflinger, Friedrich, Friedrich Dorner, & Falko G. Falkner. (1992). Construction of chimeric vaccinia viruses by molecular cloning and packaging.. Proceedings of the National Academy of Sciences. 89(21). 9977–9981. 36 indexed citations

20.

Mocikat, Ralph, Falko G. Falkner, Ronald Mertz, & Hans G. Zachau. (1986). Upstream regulatory sequences of immunoglobulin genes are recognized by nuclear proteins which also bind to other gene regions. Nucleic Acids Research. 14(22). 8829–8844. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact